The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
ALS Genes in the Genomic Era and their Implications for FTD
Open accessAbstract
CRISPR/Cas9: a gene-editing technology that can target and edit parts of the genome with high accuracy.Disease anticipation: a phenomenon whereby a genetic disorder presents with earlier disease onset and increased disease severity as it is passed on from one generation to the next.The underlying disease mechanism is a dynamic mutation or repeat expansion in the DNA, such as is seen in Huntington's disease.DNA damage response: a cellular network involved in detecting, signaling, and repairing DNA damage.Genetic modifier: a genetic factor that can modify the expression level of a particular gene.Loss-of-function (LOF) mutation: mutation resulting in the loss or reduction of protein or protein function.Massive parallel sequencing (MPS): also known as nextgeneration sequencing (NGS), is a non-Sanger-based high-throughput DNA sequencing approach generating millions to billions of sequence reads in parallel.Missense mutation: a point mutation in which a single nucleotide change results in a codon for another amino acid.Nonsense-mediated mRNA decay (NMD): a surveillance pathway that degrades mRNAs carrying premature termination codons.Oligogenic model: an inheritance model in which mutations in different genes work together to cause disease.Penetrance: the percentage of individuals carrying a disease-causing genetic variant that expresses the disease phenotype.Pleiotropy: a genetic phenomenon whereby certain gene mutations or variants can influence more than one distinct clinical phenotype.Proteostasis: or protein homeostasis is a biological process that regulates the abundance and folding of proteins within the cells.Repeat-associated non-AUG (RAN) translation: a noncanonical translational process producing OPTN Optineurin RAB8 Ras-related protein Rab-8 RAB39 Ras-related protein Rab-39 RRM2 Ribonucleoside-diphosphate reductase subunit M2 SCF Skp1-Cul1-F-box SMCR8 Smith-Magenis syndrome chromosome region, candidate 8 homolog SQSTM1/p62 Sequestosome 1 TARDBP/TDP-43 TAR DNA-binding protein VAPB Vesicle-associated membrane protein-associated protein B/C WDR41 WD repeat domain 41
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Moloney, C. M., Rayaprolu, S., Howard, J. C., Fromholt, S., Brown, H. H., Collins, M., Cabrera, M., Duffy, C., Siemienski, Z. B., Miller, D., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0393-5 · Cited by 15
RetractedDeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811
State of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS
Kim, H. J., Kim, N. C., Wang, Y.-D., Scarborough, E. A., Moore, J., Diaz, Z., MacLea, K. S., Freibaum, B., Li, S., Molliex, A., et al. (2013) · Nature · doi:10.1038/nature11922 · Cited by 1,475
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,415
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Elden, A. C., Kim, H.-J., Hart, M. P., Chen-Plotkin, A. S., Johnson, B. S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M. M., et al. (2010) · Nature · doi:10.1038/nature09320 · Cited by 1,325
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,058
The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., Steinwald, P., Daley, E. L., Miller, S. J., Cunningham, K. M., Vidensky, S., et al. (2015) · Nature · doi:10.1038/nature14973 · Cited by 982
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond, C. S., Couthouis, J., Lu, Y.-F., Wang, Q., Krueger, B. J., et al. (2015) · Science · doi:10.1126/science.aaa3650 · Cited by 966
The changing scene of amyotrophic lateral sclerosis
Robberecht, W., & Philips, T. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3430 · Cited by 957
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R., Mitchell, J., Lyon, M., & Moore, D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447 · Cited by 909
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
Prevalence and patterns of cognitive impairment in sporadic ALS
Ringholz, G. M., Appel, S. H., Bradshaw, M., Cooke, N. A., Mosnik, D. M., & Schulz, P. E. (2005) · Neurology · doi:10.1212/01.wnl.0000172911.39167.b6 · Cited by 844
GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport
Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., Lee, K.-H., Badders, N., Valentine, M., Miller, B. L., Wong, P. C., et al. (2015) · Nature · doi:10.1038/nature14974 · Cited by 841
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Freischmidt, A., Wieland, T., Richter, B., Ruf, W., Schaeffer, V., Müller, K., Marroquin, N., Nordin, F., Hübers, A., Weydt, P., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4000 · Cited by 786
Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria
Nykamp, K., Anderson, M., Powers, M., Garcia, J., Herrera, B., Ho, Y.-Y., Kobayashi, Y., Patil, N., Thusberg, J., Westbrook, M., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.37 · Cited by 762
Richter, B., Sliter, D. A., Herhaus, L., Stolz, A., Wang, C., Beli, P., Zaffagnini, G., Wild, P., Martens, S., Wagner, S. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523926113 · Cited by 755
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O. C., Pietrzyk, J., et al. (2014) · Science · doi:10.1126/science.1256800 · Cited by 740
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
<emph type="ital">SQSTM1</emph> Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Fecto, F. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.250 · Cited by 650
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Gordon, P. H., Moore, D. H., Miller, R. G., Florence, J. M., Verheijde, J. L., Doorish, C., Hilton, J. F., Spitalny, G. M., MacArthur, R. B., Mitsumoto, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70270-3 · Cited by 649
Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells
Kwon, I., Xiang, S., Kato, M., Wu, L., Theodoropoulos, P., Wang, T., Kim, J., Yun, J., Xie, Y., & McKnight, S. L. (2014) · Science · doi:10.1126/science.1254917 · Cited by 646
Mackenzie, I. R., Nicholson, A. M., Sarkar, M., Messing, J., Purice, M. D., Pottier, C., Annu, K., Baker, M., Perkerson, R. B., Kurti, A., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.025 · Cited by 640
Gijselinck, I., Van Langenhove, T., van der Zee, J., Sleegers, K., Philtjens, S., Kleinberger, G., Janssens, J., Bettens, K., Van Cauwenberghe, C., Pereson, S., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70261-7 · Cited by 633
Self-citationMiller, T. M., Pestronk, A., David, W., Rothstein, J., Simpson, E., Appel, S. H., Andres, P. L., Mahoney, K., Allred, P., Alexander, K., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70061-9 · Cited by 617
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis
Wu, C.-H., Fallini, C., Ticozzi, N., Keagle, P. J., Sapp, P. C., Piotrowska, K., Lowe, P., Koppers, M., McKenna-Yasek, D., Baron, D. M., et al. (2012) · Nature · doi:10.1038/nature11280 · Cited by 603
Jovičić, A., Mertens, J., Boeynaems, S., Bogaert, E., Chai, N., Yamada, S. B., Paul, J. W., Sun, S., Herdy, J. R., Bieri, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4085 · Cited by 598
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., et al. (2017) · Nature · doi:10.1038/nature22038 · Cited by 571
PARALS Registry, van Rheenen, W., SLALOM Group, SLAP Registry, FALS Sequencing Consortium, SLAGEN Consortium, NNIPPS Study Group, Shatunov, A., Dekker, A. M., McLaughlin, R. L., et al. (2016) · Nature Genetics · doi:10.1038/ng.3622 · Cited by 571
Lagier-Tourenne, C., Baughn, M., Rigo, F., Sun, S., Liu, P., Li, H.-R., Jiang, J., Watt, A. T., Chun, S., Katz, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318835110 · Cited by 561
Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis
Zou, Z.-Y., Zhou, Z.-R., Che, C.-H., Liu, C.-Y., He, R.-L., & Huang, H.-P. (2017) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-315018 · Cited by 540
Jiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536
Mori, K., Arzberger, T., Grässer, F. A., Gijselinck, I., May, S., Rentzsch, K., Weng, S.-M., Schludi, M. H., van der Zee, J., Cruts, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1189-3 · Cited by 496
Self-citationBannwarth, S., Ait-El-Mkadem, S., Chaussenot, A., Genin, E. C., Lacas-Gervais, S., Fragaki, K., Berg-Alonso, L., Kageyama, Y., Serre, V., Moore, D. G., et al. (2014) · Brain · doi:10.1093/brain/awu138 · Cited by 488
TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail
Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S., Ayala, Y. M., & Baralle, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505557200 · Cited by 460
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis
ITALSGEN, Johnson, J. O., Pioro, E. P., Boehringer, A., Chia, R., Feit, H., Renton, A. E., Pliner, H. A., Abramzon, Y., Marangi, G., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3688 · Cited by 445
C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits
Chew, J., Gendron, T. F., Prudencio, M., Sasaguri, H., Zhang, Y.-J., Castanedes-Casey, M., Lee, C. W., Jansen-West, K., Kurti, A., Murray, M. E., et al. (2015) · Science · doi:10.1126/science.aaa9344 · Cited by 409
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
Scotter, E. L., Chen, H.-J., & Shaw, C. E. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0338-x · Cited by 382
Mackenzie, I. R. A., & Neumann, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13588 · Cited by 381
Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS
Smith, B. N., Ticozzi, N., Fallini, C., Gkazi, A. S., Topp, S., Kenna, K. P., Scotter, E. L., Kost, J., Keagle, P., Miller, J. W., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.09.027 · Cited by 367
Abe, K., Itoyama, Y., Sobue, G., Tsuji, S., Aoki, M., Doyu, M., Hamada, C., Kondo, K., Yoneoka, T., Akimoto, M., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.959024 · Cited by 365
Targeting mi R‐155 restores abnormal microglia and attenuates disease in SOD 1 mice
Butovsky, O., Jedrychowski, M. P., Cialic, R., Krasemann, S., Murugaiyan, G., Fanek, Z., Greco, D. J., Wu, P. M., Doykan, C. E., Kiner, O., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24304 · Cited by 358
Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis
Byrne, S., Walsh, C., Lynch, C., Bede, P., Elamin, M., Kenna, K., McLaughlin, R., & Hardiman, O. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.224501 · Cited by 351
Funayama, M., Ohe, K., Amo, T., Furuya, N., Yamaguchi, J., Saiki, S., Li, Y., Ogaki, K., Ando, M., Yoshino, H., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70266-2 · Cited by 351
Motor Neuron dysfunction in frontotemporal dementia
Burrell, J. R., Kiernan, M. C., Vucic, S., & Hodges, J. R. (2011) · Brain · doi:10.1093/brain/awr195 · Cited by 348
Evidence for an oligogenic basis of amyotrophic lateral sclerosis
van Blitterswijk, M., van Es, M. A., Hennekam, E. A. M., Dooijes, D., van Rheenen, W., Medic, J., Bourque, P. R., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds199 · Cited by 341
Zhang, Y.-J., Jansen-West, K., Xu, Y.-F., Gendron, T. F., Bieniek, K. F., Lin, W.-L., Sasaguri, H., Caulfield, T., Hubbard, J., Daughrity, L., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1336-5 · Cited by 337
Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
Marin, B., Boumédiene, F., Logroscino, G., Couratier, P., Babron, M.-C., Leutenegger, A. L., Copetti, M., Preux, P.-M., & Beghi, E. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw061 · Cited by 325
An estimate of amyotrophic lateral sclerosis heritability using twin data
Al-Chalabi, A., Fang, F., Hanby, M. F., Leigh, P. N., Shaw, C. E., Ye, W., & Rijsdijk, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.207464 · Cited by 323
TBK1: a new player in ALS linking autophagy and neuroinflammation
Oakes, J. A., Davies, M. C., & Collins, M. O. (2017) · Molecular Brain · doi:10.1186/s13041-017-0287-x · Cited by 319
Pottier, C., Bieniek, K. F., Finch, N., van de Vorst, M., Baker, M., Perkersen, R., Brown, P., Ravenscroft, T., van Blitterswijk, M., Nicholson, A. M., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1436-x · Cited by 312
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis
SLAGEN Consortium, Kenna, K. P., van Doormaal, P. T. C., Dekker, A. M., Ticozzi, N., Kenna, B. J., Diekstra, F. P., van Rheenen, W., van Eijk, K. R., Jones, A. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3626 · Cited by 287
Gendron, T. F., Chew, J., Stankowski, J. N., Hayes, L. R., Zhang, Y.-J., Prudencio, M., Carlomagno, Y., Daughrity, L. M., Jansen-West, K., Perkerson, E. A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai7866 · Cited by 265
Fallini, C., Bassell, G. J., & Rossoll, W. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds205 · Cited by 247
Smith, B. N., Topp, S. D., Fallini, C., Shibata, H., Chen, H.-J., Troakes, C., King, A., Ticozzi, N., Kenna, K. P., Soragia-Gkazi, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9157 · Cited by 247
on behalf of the BELNEU CONSORTIUM, Gijselinck, I., Van Mossevelde, S., van der Zee, J., Sieben, A., Engelborghs, S., De Bleecker, J., Ivanoiu, A., Deryck, O., Edbauer, D., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.159 · Cited by 242
Toxic PR n poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export
Shi, K. Y., Mori, E., Nizami, Z. F., Lin, Y., Kato, M., Xiang, S., Wu, L. C., Ding, M., Yu, Y., Gall, J. G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620293114 · Cited by 242
Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice
Koval, E. D., Shaner, C., Zhang, P., du Maine, X., Fischer, K., Tay, J., Chau, B. N., Wu, G. F., & Miller, T. M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt261 · Cited by 236
De Vos, K. J., & Hafezparast, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.004 · Cited by 236
Mackenzie, I. R. A., Frick, P., Grässer, F. A., Gendron, T. F., Petrucelli, L., Cashman, N. R., Edbauer, D., Kremmer, E., Prudlo, J., Troost, D., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1476-2 · Cited by 231
Cady, J., Allred, P., Bali, T., Pestronk, A., Goate, A., Miller, T. M., Mitra, R. D., Ravits, J., Harms, M. B., & Baloh, R. H. (2015) · Annals of Neurology · doi:10.1002/ana.24306 · Cited by 220
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
Williams, K. L., Topp, S., Yang, S., Smith, B., Fifita, J. A., Warraich, S. T., Zhang, K. Y., Farrawell, N., Vance, C., Hu, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11253 · Cited by 206
Genin, E. C., Plutino, M., Bannwarth, S., Villa, E., Cisneros‐Barroso, E., Roy, M., Ortega‐Vila, B., Fragaki, K., Lespinasse, F., Pinero‐Martos, E., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505496 · Cited by 199
Tran, H., Almeida, S., Moore, J., Gendron, T. F., Chalasani, U., Lu, Y., Du, X., Nickerson, J. A., Petrucelli, L., Weng, Z., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.09.015 · Cited by 195
Myotonic dystrophy: RNA-mediated muscle disease
Wheeler, T. M., & Thornton, C. A. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282ef6064 · Cited by 181
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
Gijselinck, I., Van Mossevelde, S., van der Zee, J., Sieben, A., Philtjens, S., Heeman, B., Engelborghs, S., Vandenbulcke, M., De Baets, G., Bäumer, V., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002220 · Cited by 174
Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing
Kenna, K. P., McLaughlin, R. L., Byrne, S., Elamin, M., Heverin, M., Kenny, E. M., Cormican, P., Morris, D. W., Donaghy, C. G., Bradley, D. G., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101795 · Cited by 170
Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis
Sawada, H. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1319937 · Cited by 170
Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum
Cruts, M., Gijselinck, I., Van Langenhove, T., van der Zee, J., & Van Broeckhoven, C. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.04.010 · Cited by 165
Self-citationHomozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia
Fratta, P., Poulter, M., Lashley, T., Rohrer, J. D., Polke, J. M., Beck, J. A., Ryan, N. S., Moss, D. J. H., Mizielinska, S., Waite, A. J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1147-0 · Cited by 163
Williams, J. R., Trias, E., Beilby, P. R., Lopez, N. I., Labut, E. M., Bradford, C. S., Roberts, B. R., McAllum, E. J., Crouch, P. J., Rhoads, T. W., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.020 · Cited by 163
Coelho, M. B., Attig, J., Bellora, N., König, J., Hallegger, M., Kayikci, M., Eyras, E., Ule, J., & Smith, C. W. (2015) · The EMBO Journal · doi:10.15252/embj.201489852 · Cited by 162
Welander distal myopathy is caused by a mutation in the RNA‐binding protein TIA1
Hackman, P., Sarparanta, J., Lehtinen, S., Vihola, A., Evilä, A., Jonson, P. H., Luque, H., Kere, J., Screen, M., Chinnery, P. F., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23831 · Cited by 159
Lattante, S., Ciura, S., Rouleau, G. A., & Kabashi, E. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.03.005 · Cited by 159
Matrin 3 Binds and Stabilizes mRNA
Salton, M., Elkon, R., Borodina, T., Davydov, A., Yaspo, M.-L., Halperin, E., & Shiloh, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023882 · Cited by 159
Amyotrophic lateral sclerosis and environmental factors
Bozzoni, V., Pansarasa, O., Diamanti, L., Nosari, G., Cereda, C., & Ceroni, M. (2016) · Functional Neurology · doi:10.11138/fneur/2016.31.1.007 · Cited by 159
NEK1 mutations in familial amyotrophic lateral sclerosis
Brenner, D., Müller, K., Wieland, T., Weydt, P., Böhm, S., Lulé, D. E., Hübers, A., Neuwirth, C., Weber, M., Borck, G., et al. (2016) · Brain · doi:10.1093/brain/aww033 · Cited by 154
Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage
Hill, S. J., Mordes, D. A., Cameron, L., Neuberg, D. S., Landini, S., Eggan, K. C., & Livingston, D. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611673113 · Cited by 153
Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity
Woo, J. A., Liu, T., Trotter, C., Fang, C. C., Narvaez, E. D., LePochat, P., Maslar, D., Bukhari, A., Zhao, X., Deonarine, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15558 · Cited by 150
Relationship between C9orf72 repeat size and clinical phenotype
Mossevelde, S. V., van der Zee, J., Cruts, M., & Broeckhoven, C. V. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.02.008 · Cited by 148
Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis
Johnson, J. O., Glynn, S. M., Gibbs, J. R., Nalls, M. A., Sabatelli, M., Restagno, G., Drory, V. E., Chiò, A., Rogaeva, E. A., & Traynor, B. J. (2014) · Brain · doi:10.1093/brain/awu265 · Cited by 145
Kaneb, H., Folkmann, A. W., Belzil, V., Jao, L.-E., Leblond, C. S., Girard, S., Daoud, H., Noreau, A., Rochefort, D. L., Hince, P., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu545 · Cited by 145
Tu, Z., Yang, W., Yan, S., Guo, X., & Li, X. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0031-x · Cited by 143
Fogh, I., Ratti, A., Gellera, C., Lin, K., Tiloca, C., Moskvina, V., Corrado, L., Sorarú, G., Cereda, C., Corti, S. P., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt587 · Cited by 143
Yang, D., Abdallah, A., Li, Z., Lu, Y., Almeida, S., & Gao, F. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1448-6 · Cited by 139
Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD
Khosravi, B., Hartmann, H., May, S., Möhl, C., Ederle, H., Michaelsen, M., Schludi, M. H., Dormann, D., & Edbauer, D. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw432 · Cited by 137
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration
van der Zee, J., Langenhove, T. V., Kovács, G. G., Dillen, L., Deschamps, W., Engelborghs, S., Matěj, R., Vandenbulcke, M., Sieben, A., Dermaut, B., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1298-7 · Cited by 129
Klar, J., Sobol, M., Melberg, A., Mäbert, K., Ameur, A., Johansson, A., Feuk, L., Entesarian, M., Örlén, H., Casar‐Borota, O., et al. (2013) · Human Mutation · doi:10.1002/humu.22282 · Cited by 129
Chaussenot, A., Ber, I. L., Ait-El-Mkadem, S., Camuzat, A., de Septenville, A. L., Bannwarth, S., Genin, E. C., Serre, V., Augé, G., Brice, A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.022 · Cited by 129
van der Zee, J., Gijselinck, I., Mossevelde, S. V., Perrone, F., Dillen, L., Heeman, B., Bäumer, V., Engelborghs, S., Bleecker, J. D., Baets, J., et al. (2016) · Human Mutation · doi:10.1002/humu.23161 · Cited by 123
Müller, K., Andersen, P. M., Hübers, A., Marroquin, N., Volk, A. E., Danzer, K. M., Meitinger, T., Ludolph, A. C., Strom, T. M., & Weishaupt, J. H. (2014) · Brain · doi:10.1093/brain/awu227 · Cited by 121
Mutation analysis ofCHCHD10in different neurodegenerative diseases
Zhang, M., Xi, Z., Zinman, L. H., Bruni, A. C., Maletta, R., Curcio, S. A. M., Rainero, I., Rubino, E., Pinessi, L., Nacmias, B., et al. (2015) · Brain · doi:10.1093/brain/awv082 · Cited by 119
The mammalian Nek1 kinase is involved in primary cilium formation
Shalom, O., Shalva, N., Altschuler, Y., & Motro, B. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.036 · Cited by 116
Ajroud‐Driss, S., Fecto, F., Ajroud, K., Lalani, I., Calvo, S. E., Mootha, V. K., Deng, H., Siddique, N., Tahmoush, A. J., Heiman-Patterson, T. D., et al. (2014) · Neurogenetics · doi:10.1007/s10048-014-0421-1 · Cited by 114
A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK
Morgan, S. L., Shatunov, A., Sproviero, W., Jones, A. R., Shoai, M., Hughes, D., Khleifat, A. A., Malaspina, A., Morrison, K. E., Shaw, P. J., et al. (2017) · Brain · doi:10.1093/brain/awx082 · Cited by 110
Yin, S., Lopez-Gonzalez, R., Kunz, R. C., Gangopadhyay, J. P., Borufka, C., Gygi, S. P., Gao, F., & Reed, R. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.056 · Cited by 108
D’Angiolella, V., Esencay, M., & Pagano, M. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.10.011 · Cited by 99
Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders
Lattante, S., Millecamps, S., Stévanin, G., Rivaud-Péchoux, S., Moigneu, C., Camuzat, A., da Barroca, S., Mundwiller, E., Couarch, P., Salachas, F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000778 · Cited by 99
Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1
Chen, Y., Craigen, W. J., & Riley, D. J. (2009) · Cell Cycle · doi:10.4161/cc.8.2.7551 · Cited by 98
Chen, Y., Chen, C., Riley, D. J., & Chen, P. (2011) · Cell Cycle · doi:10.4161/cc.10.4.14814 · Cited by 98
Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis
Lin, K., Tsai, P., Liao, Y., Chen, W., Tsai, C., Soong, B., & Lee, Y. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.008 · Cited by 98
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers
van Blitterswijk, M., Mullen, B., Heckman, M. G., Baker, M., DeJesus‐Hernandez, M., Brown, P. H., Murray, M. E., Hsiung, G. R., Stewart, H. G., Karydas, A. M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.016 · Cited by 97
Boehringer, A. V., Garcia‐Mansfield, K., Singh, G. M., Bakkar, N., Pirrotte, P., & Bowser, R. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-14924-6 · Cited by 91
The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair
Fang, X., Lin, H., Wang, X., Zuo, Q., Qin, J., & Zhang, P. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv076 · Cited by 90
Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients
Perrone, F., Nguyen, H. P., Mossevelde, S. V., Moisse, M., Sieben, A., Santens, P., Bleecker, J. D., Vandenbulcke, M., Engelborghs, S., Baets, J., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.008 · Cited by 87
Self-citationStraub, I. R., Janer, A., Weraarpachai, W., Zinman, L. H., Robertson, J., Rogaeva, E. A., & Shoubridge, E. A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx393 · Cited by 87
The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons
Chang, J., Baloh, R. H., & Milbrandt, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.048975 · Cited by 86
Yamaguchi, A., & Takanashi, K. (2016) · Scientific Reports · doi:10.1038/srep35195 · Cited by 82
Nek1 silencing slows down DNA repair and blocks DNA damage-induced cell cycle arrest
Pelegrini, A. L., Moura, D. J., Brenner, B. L., Ledur, P. F., Maques, G. P., Henriques, J. A. P., Saffi, J., & Lenz, G. (2010) · Mutagenesis · doi:10.1093/mutage/geq026 · Cited by 80
Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis
Leblond, C. S., Gan‐Or, Z., Spiegelman, D., Laurent, S. B., Szuto, A., Hodgkinson, A., Dionne‐Laporte, A., Provencher, P., de Carvalho, M. A., Orrù, S., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.013 · Cited by 80
Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control
Klein, D. K., Hoffmann, S., Ahlskog, J. K., O’Hanlon, K. A., Quaas, M., Larsen, B. D., Rolland, B., Rösner, H. I., Walter, D., Kousholt, A. N., et al. (2015) · Nature Communications · doi:10.1038/ncomms6800 · Cited by 77
Genetic architecture of ALS in Sardinia
Borghero, G., Pugliatti, M., Marrosu, F., Marrosu, M. G., Murru, M. R., Floris, G., Cannas, A., Parish, L. D., Occhineri, P., Cau, T. B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.012 · Cited by 77
Cognitive impairment in familial ALS
Wheaton, M. W., Salamone, A. R., Mosnik, D. M., McDonald, R. O., Appel, S. H., Schmolck, H., Ringholz, G. M., & Schulz, P. E. (2007) · Neurology · doi:10.1212/01.wnl.0000277422.11236.2c · Cited by 74
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion
Mossevelde, S. V., van der Zee, J., Gijselinck, I., Sleegers, K., Bleecker, J. D., Sieben, A., Vandenberghe, R. R., Langenhove, T. V., Baets, J., Deryck, O., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4847 · Cited by 74
Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?
Felbecker, A., Camu, W., Valdmanis, P. N., Sperfeld, A.-D., Waibel, S., Steinbach, P. J., Rouleau, G. A., Ludolph, A. C., & Andersen, P. M. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.192310 · Cited by 73
Dols‐Icardo, O., Nebot, I., Gorostidi, A., Ortega‐Cubero, S., Hernández, I., Rojas‐García, R., García‐Redondo, A., Povedano, M., Lladó, A., Álvarez, V., et al. (2015) · Brain · doi:10.1093/brain/awv175 · Cited by 72
CHCHD10mutations in Italian patients with sporadic amyotrophic lateral sclerosis: Figure 1
Ronchi, D., Riboldi, G. M., Bo, R. D., Ticozzi, N., Scarlato, M., Galimberti, D., Corti, S. P., Silani, V., Bresolin, N., & Comi, G. P. (2015) · Brain · doi:10.1093/brain/awu384 · Cited by 67
Wang, J.-S., Guo, C., Liu, S., Qi, H., Yin, Y., Liang, R., Sun, M., & Greenaway, F. T. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.031 · Cited by 66
Burden of rare variants in ALS genes influences survival in familial and sporadic ALS
Pang, S. Y.-Y., Hsu, J. S., Teo, K. C., Li, Y., Kung, M. H. W., Cheah, K. S. E., Chan, D. T.-M., Cheung, K., Li, M., Sham, P. C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.007 · Cited by 61
Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD.
Khosravi, B., Hartmann, H., May, S., Möhl, C., Ederle, H., Michaelsen, M., Schludi, M. H., Dormann, D., & Edbauer, D. (2017) · DZNE Pub · Cited by 61
Lee, A., Rayner, S. L., Gwee, S. S. L., Luca, A. D., Shahheydari, H., Sundaramoorthy, V., Ragagnin, A., Morsch, M., Radford, R. A. W., Galper, J., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2632-8 · Cited by 55
Mutational analysis of TBK1 in Taiwanese patients with amyotrophic lateral sclerosis
Tsai, P., Liu, Y., Lin, K., Liu, Y., Liao, Y., Hsiao, C.-T., Soong, B., Yip, P., & Lee, Y. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.022 · Cited by 55
July 2017 ENCALS statement on edaravone
Al‐Chalabi, A., Andersen, P. M., Chandran, S., Chiò, A., Corcia, P., Couratier, P., Danielsson, O., de Carvalho, M. A., Desnuelle, C., Grehl, T., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1369125 · Cited by 52
Ciura, S., Sellier, C., Campanari, M., Charlet‐Berguerand, N., & Kabashi, E. (2016) · Autophagy · doi:10.1080/15548627.2016.1189070 · Cited by 51
Genetic epidemiology of motor neuron disease-associated variants in the Scottish population
Black, H. A., Leighton, D., Cleary, E. M., Rose, E., Stephenson, L. J., Colville, S., Ross, D. B., Warner, J. P., Porteous, M. E., Gorrie, G., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.013 · Cited by 50
Hogan, A. L., Don, E. K., Rayner, S. L., Lee, A., Laird, A. S., Watchon, M., Winnick, C. G., Tarr, I. S., Morsch, M., Fifita, J. A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx136 · Cited by 50
NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients
Nguyen, H. P., Mossevelde, S. V., Dillen, L., Bleecker, J. D., Moisse, M., Damme, P. V., Broeckhoven, C. V., van der Zee, J., Engelborghs, S., Crols, R., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.021 · Cited by 49
Self-citationKurzwelly, D., Krüger, S., Biskup, S., & Heneka, M. T. (2015) · Brain · doi:10.1093/brain/awv014 · Cited by 49
Bury, J. J., Highley, J. R., Cooper‐Knock, J., Goodall, G., Higginbottom, A., McDermott, C. J., Ince, P. G., Shaw, P. J., & Kirby, J. (2015) · Neuropathology · doi:10.1111/neup.12240 · Cited by 48
Axial Spondylometaphyseal Dysplasia Is Caused by C21orf2 Mutations
Wang, Z., Iida, A., Miyake, N., Nishiguchi, K. M., Fujita, K., Nakazawa, T., Alswaid, A. F., Balwi, M. A. A., Kim, O.-H., Cho, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150555 · Cited by 48
Matrin 3 variants are frequent in Italian ALS patients
Marangi, G., Lattante, S., Doronzio, P. N., Conte, A., Tasca, G. A., Monforte, M., Patanella, A. K., Bisogni, G., Meleo, E., Spada, S. L., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.09.023 · Cited by 48
Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin
Williams, K. L., McCann, E. P., Fifita, J. A., Zhang, K., Duncan, E. L., Leo, P. J., Marshall, M. S., Rowe, D. B., Nicholson, G. A., & Blair, I. P. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.013 · Cited by 45
Giannoccaro, M. P., Bartoletti‐Stella, A., Piras, S., Pession, A., Massis, P. D., Oppi, F., Maserati, M. S., Pasini, E., Baiardi, S., Avoni, P., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8540-x · Cited by 43
A novel Arg147Trp MATR3 missense mutation in a slowly progressive ALS Italian patient
Origone, P., Verdiani, S., Poggio, M., Zuccarino, R., Vignolo, M., Caponnetto, C., & Mandich, P. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1058397 · Cited by 38
A look into the future of ALS research
Clerc, P., Lipnick, S., & Willett, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.002 · Cited by 38
Drugs in clinical development for the treatment of amyotrophic lateral sclerosis
Martínez, A., Palomo, V., Pérez, D. I., & Gil, C. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1302426 · Cited by 38
MATR3 mutation analysis in a Chinese cohort with sporadic amyotrophic lateral sclerosis
Xu, L., Li, J., Tang, L., Zhang, N., & Fan, D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.023 · Cited by 37
Axial spondylometaphyseal dysplasia is also caused by NEK1 mutations
Wang, Z., Horemuzova, E., Iida, A., Guo, L. Z., Liu, Y., Matsumoto, N., Nishimura, G., Nordgren, A., Miyake, N., Tham, E., et al. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2016.157 · Cited by 36
Dekker, A. M., Seelen, M., van Doormaal, P. T. C., van Rheenen, W., Bothof, R., van Riessen, T., Brands, W. J., van der Kooi, A. J., de Visser, M., Voermans, N. C., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.012 · Cited by 35
Hogan, A. L., Don, E. K., Rayner, S. L., Lee, A., Laird, A. S., Watchon, M., Winnick, C. G., Tarr, I. S., Morsch, M., Fifita, J. A., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy362 · Cited by 35
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
Nizzardo, M., Simoné, C., Rizzo, F., Ulzi, G., Ramirez, A., Rizzuti, M., Bordoni, A., Bucchia, M., Gatti, S., Bresolin, N., et al. (2016) · Scientific Reports · doi:10.1038/srep21301 · Cited by 34
Che, X., Zhao, Q., Huang, Y. M., Li, X., Ren, R., Chen, S., Wang, G., & Guo, Q. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170426105713 · Cited by 33
Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia
Langenhove, T. V., Piguet, O., Burrell, J. R., Leyton, C. E., Foxe, D., Abela, M., Bartley, L., Kim, W. S., Jary, E., Huang, Y. M., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161272 · Cited by 24
Kim, Y.-E., Oh, K., Noh, M., Nahm, M., Park, J., Lim, S. M., Jang, J., Cho, E., Ki, C., Lee, S., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.003 · Cited by 23
C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Cruts, M., Engelborghs, S., van der Zee, J., & Broeckhoven, C. V. (2015) · VUBIR (Vrije Universiteit Brussel) · Cited by 19
Pan, C., Jiao, B., Xiao, T., Hou, L., Zhang, W., Liu, X., Xu, J. L., Tang, B., & Shen, L. H. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1293111 · Cited by 19
Pribadi, M., Yang, Z., Kim, T. S., Swartz, E. W., Huang, A., Chen, J., Dokuru, D. R., Baek, J., Gao, F., Fua, A., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/051193 · Cited by 18
Shu, S., Li, X. L., Liu, Q. F., Liu, F., Cui, B., Liu, M. S., Cui, L., Li, X., & Zhang, X. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1183681 · Cited by 18
CHCHD10 mutations in patients with amyotrophic lateral sclerosis in Mainland China
Shen, S., He, J., Tang, L., Zhang, N., & Fan, D. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.02.011 · Cited by 15
Cited by
Feldman, E. L., Goutman, S. A., Petri, S., Mazzini, L., Savelieff, M. G., Shaw, P. J., & Sobue, G. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01272-7 · Cited by 1,129
The genetic architecture of Parkinson's disease
Blauwendraat, C., Nalls, M. A., & Singleton, A. B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30287-x · Cited by 1,114
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
Stress granules and neurodegeneration
Wolozin, B., & Ivanov, P. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0222-5 · Cited by 810
RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43
Mann, J. R., Gleixner, A. M., Mauna, J. C., Gomes, E., DeChellis-Marks, M. R., Needham, P. G., Copley, K. E., Hurtle, B., Portz, B., Pyles, N. J., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.048 · Cited by 537
Metadata
- Authors
- Nguyen, H. P., Van Broeckhoven, C., & van der Zee, J.
- Venue
- Trends in Genetics
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 34
- Issue
- 6
- Pages
- 404-423
- ISSN
- 0168-9525 (ISSN-L)
- OpenAlex
- W2794926869
- Cited by
- 307
- References
- 154
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.